Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended Insider Trades

Insider Trading History

Track insider trading activity for Kevin Appelbaum, Or His Successor(s), As Trustee Of The Kevin Appelbaum Revocable Trust Under Revocable Trust Declaration Dated 5/16/2020, As Amended. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Director
Holding Value $2.71M 235,000 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.71M 235,000 shares
$11.54
$11.54
Better Therapeutics
Better Therapeutics BTTX
Director
Holding Value $0.625 6,250 shares
Last Trade
Mar 31, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.93k 2,500 shares
$1.97
$0.00
Better Therapeutics
Better Therapeutics BTTX
Director
Holding Value $23.5 235,000 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 235,000 shares
$1.98
$0.00
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right )
Mountain Crest Acquisition II - Units (1 Ord Share & 1 Right ) MCADU
Director
Holding Value $72.1k 6,250 shares
Last Trade
Mar 31, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$28.9k 2,500 shares
$11.54
$11.54
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Director
Holding Value $242k 235,000 shares
Last Trade
Mar 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$242k 235,000 shares
$1.03
$1.03
Better Therapeutics- Tradeable Rights - March 2021
Better Therapeutics- Tradeable Rights - March 2021 MCADR
Director
Holding Value $6.44k 6,250 shares
Last Trade
Mar 31, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.58k 2,500 shares
$1.03
$1.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up